Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 26 May 2009. doi:10.1136/jmg.2009.068361
Journal of Medical Genetics 2009;46:649-656
Copyright © 2009 by the BMJ Publishing Group Ltd.

REVIEW

Long-range regulation at the SOX9 locus in development and disease

C T Gordon1, T Y Tan1,2,3, S Benko4, D FitzPatrick5, S Lyonnet4,6, P G Farlie1

1 Craniofacial Development Laboratory, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia
2 Department of Paediatrics, University of Melbourne, Parkville, Australia
3 Genetic Health Services Victoria, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia
4 INSERM U-781, Hôpital Necker-Enfants Malades, Paris, France
5 MRC Human Genetics Unit, Institute of Genetic and Molecular Medicine, Edinburgh, UK
6 Université Paris Descartes et Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France

Correspondence to Dr P Farlie, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC 3052, Australia; peter.farlie{at}mcri.edu.au

ABSTRACT

The involvement of SOX9 in congenital skeletal malformation was demonstrated 15 years ago with the identification of mutations in and around the gene in patients with campomelic dysplasia (CD). Translocations upstream of the coding sequence suggested that altered expression of SOX9 was capable of severely impacting on skeletal development. Subsequent studies in humans and animal models pointed towards a complex regulatory region controlling SOX9 transcription, involving ~1 Mb of upstream sequence. Recent data indicate that this regulatory domain may extend substantially further, with identification of several disruptions greater than 1 Mb upstream of SOX9 associated with isolated Pierre Robin sequence (PRS), a craniofacial disorder that is frequently a component of CD. The translocation breakpoints upstream of SOX9 can now be clustered into three groups, with a trend towards less severe skeletal phenotypes as the distance of each cluster from SOX9 increases. In this review we discuss how the identification of novel lesions surrounding SOX9 support the existence of tissue specific enhancers acting over a large distance to regulate expression of the gene during craniofacial development, and we highlight the potential for discovery of additional regulatory elements within the extended SOX9 control region.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs